Treatment of low-grade intermediate-risk nonmuscle-invasive bladder cancer with ugn-102 ± transurethral resection of bladder tumor (turbt) compared to turbt monotherapy: the phase 3 atlas trial
Urologic Oncology: Seminars and Original Investigations(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要